Soybean Extracts AND Isolates

Monograph

234products

product · Oral

Accepted Names (English)

7-O-beta-D-Glucopyranoside(common)Black soya bean(common)Da dou(common)Genistein(common)Genistein 7-glucoside(common)Genistin(common)Soy(common)Soy isoflavone extract(common)Soy protein concentrate(common)Soy protein isolate(common)Soya(common)Soyabean(common)Soybean(common)4',5,7-Trihydroxyisoflavone(proper)5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one(proper)7-(beta-D-glucopyranosyloxy)-3-(4- hydroxyphenyl)-4H-1-Benzopyran-4-one(proper)Glycine max(proper)Soy isoflavone extract(proper)Soy protein concentrate(proper)Soy protein isolate 1(proper)

Accepted Names (French)

Approved Health Claims

Helps to attenuate/reduce/decrease bone (mineral density (BMD)) loss in postmenopausal women when used in conjunction with adequate amounts of calcium and vitamin D
May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats)

Approved Health Claims (Français)

Helps to attenuate/reduce/decrease bone (mineral density (BMD)) loss in postmenopausal women when used in conjunction with adequate amounts of calcium and vitamin D
May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats)

Approved Dose Ranges

Population	Dose Range	Frequency
Perimenopausal women; Postmenopausal women (D'Anna et al. 2007; Nahas et al. 2007; Crisafulli et al. 2004; Albert et al. 2002; Faure et al. 2002; Han et al. 2002; Scambia et al. 2000; Upmalis et al. 2000; Albertazzi et al. 1998).	75–125 milligrams	per day
Perimenopausal women; Postmenopausal women (D'Anna et al. 2007; Nahas et al. 2007; Crisafulli et al. 2004; Albert et al. 2002; Faure et al. 2002; Han et al. 2002; Scambia et al. 2000; Upmalis et al. 2000; Albertazzi et al. 1998).	30–125 milligrams	per day
Perimenopausal women; Postmenopausal women (D'Anna et al. 2007; Nahas et al. 2007; Crisafulli et al. 2004; Albert et al. 2002; Faure et al. 2002; Han et al. 2002; Scambia et al. 2000; Upmalis et al. 2000; Albertazzi et al. 1998).	15–125 milligrams	per day

Cautions & Contraindications

cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you are not up-to-date on mammograms and gynaecological evaluations (Tomar and Shiao 2008; BfR 2007; Duffy et al. 2007; Palacios et al. 2007; Unfer et al. 2004; Petrakis et al. 1996).

cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or any hormone replacement therapy (Rios et al. 2008; BfR 2007; Messina and Redmond 2006; ASHP 2005; Izzo et al. 2005; Mills and Bone 2005; Franco et al. 2004; Mazer 2004; Murray et al. 2003; Cambria-Keily 2002; Bell and Ovalle 2001; IOM 2001; Hansten et al. 1997; Petrakis et al. 1996).

cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder or a history of hormonal or gynaecological disease (NIH 2022; Cecchi et al. 2009; Chandrareddy et al. 2008; Gasteyger et al. 2008; Tomar and Shiao 2008; Jefferson et al. 2007; Palacios et al. 2007; Kaari et al. 2006; Noel et al. 2006; Maskarinec et al. 2004a; Maskarinec et al. 2004b; Unfer et al. 2004; Borghi-Scoazec et al. 2002; Wu et al. 2000; Duncan et al. 1999b; Hargreaves et al. 1999; McMichael-Phillips et al. 1998; Petrakis et al. 1996).

contraindicationDo not use if you have or had breast cancer or tumours or a predisposition to breast cancer, as indicated by an abnormal mammogram or biopsy, or a family member with breast cancer (Helferich et al. 2008; Tomar and Shiao 2008; BfR 2007; Duffy et al. 2007; Kaari et al. 2006; Nikander et al. 2005; Hargreaves et al. 1999; McMichael-Phillips et al. 1998; Petrakis et al. 1996).

adverse_reactionStop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if new symptoms develops such as breast pain, a recurrence of menstruation, uterine spotting or liver-related symptoms (e.g. abdominal pain, jaundice, dark urine) (Chandrareddy et al. 2008; Martinez and Lewi 2008; Palacios et al. 2007; Olawaiye et al. 2005; Albert et al. 2002; Han et al. 2002; Hargreaves et al. 1999; McMichael-Phillips et al. 1998; Petrakis et al. 1996).

Ingredients Covered

4',5,7-Trihydroxyisoflavone 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one 7-(beta-D-glucopyranosyloxy)-3-(4- hydroxyphenyl)-4H-1-Benzopyran-4-one 7-O-beta-D-Glucopyranoside Black soya bean Da dou Genistein Genistein 7-glucoside Genistin Soy Soy isoflavone extract Soy protein Soy protein concentrate Soy protein extract Soy protein isolate Soy protein isolate 1 Soya Soyabean Soybean

Validate against the Soybean Extracts AND Isolates monograph

Check if your product meets all Soybean Extracts AND Isolates monograph requirements — doses, claims, cautions, and bilingual labels.

Scan Your Product Free